Associated Papers
Human variability in glutathione-S-transferase activities, tissue distribution and major polymorphic variants: Meta-analysis and implication for chemical risk assessment.
Buratti FM et al.
Toxicology Letters, 2021
Application of pharmacogenetics in oncology.
Miteva-Marcheva NN et al.
Biomarker Research, 2020
Gene Polymorphism of Xenobiotic Biotransformation Enzymes in Patients with Classical Ph-Negative Myeloproliferative Neoplasms.
Ovsepyan VA et al.
Bulletin of Experimental Biology and Medicine, 2019
Polymorphisms of GSTM1, GSTT1, GSTP1 genes and chromosomal aberrations in lung cancer patients.
Minina VI et al.
Journal of Cancer Research and Clinical Oncology, 2017
Once-daily i.v. BU-based conditioning regimen before allogeneic hematopoietic SCT: a study of influence of GST gene polymorphisms on BU pharmacokinetics and clinical outcomes in Chinese patients.
Yin J et al.
Bone Marrow Transplantation, 2015
Potentially functional SNPs (pfSNPs) as novel genomic predictors of 5-FU response in metastatic colorectal cancer patients.
Wang J et al.
Plos One, 2014
25372392 (PubMed )
Supplement: pone.0111694.s006.pdf
Cytochrome P450 (CYP3A4*18) and glutathione-S-transferase (GSTP1) polymorphisms in a healthy Tunisian population.
Zaied C et al.
Genetic Testing and Molecular Biomarkers, 2012
[Allelic variants of polymorphic genes associated with a higher frequency of chromosome aberrations].
Sal'nikova LE et al.
Genetika, 2011
Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy.
Cecchin E et al.
The Pharmacogenomics Journal, 2011
Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients.
Ott K et al.
International Journal of Colorectal Disease, 2008
Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms.
Tran A et al.
Clinical Pharmacology and Therapeutics, 2006
Predicting drug response and toxicity based on gene polymorphisms.
Robert J et al.
Critical Reviews in Oncology/hematology, 2005
Polymorphic variation of Cyp1A1 is associated with the risk of gastric cardia cancer: a prospective case-cohort study of cytochrome P-450 1A1 and GST enzymes.
Roth MJ et al.
Cancer Causes & Control : Ccc, 2004
Select a paper to view details